Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Reshoring Debate Continues As COVID-19 Drives New Wave Of US Drug Shortages

Jan 07 2022

• By Shannon Brown

COVID-19-related manufacturing has led to shortage of critical drugs • Source: Alamy

Related Content

Real-Time Manufacturing Volume Reporting Could Help Prevent Drug Shortages, Woodcock Tells Congress

Oct 31 2019

Generic Firms Want Congress To Build On CARES Act To Prevent Critical Drug Shortages

May 01 2020

Will Continuous Manufacturing Mean Continuous Generic Delay? FDA Hears AAM's Warning

Dec 04 2017

Teva Defends Vincristine Discontinuation Decision

Oct 21 2019

Industry Fears Report-Writing Burden From Supply Chain Risk Guidance US FDA Is Drafting

Nov 09 2021

How US FDA Wants Pharmaceutical Production Volumes Reported For Drug Shortage Prevention

Nov 03 2021

Additional Topics

United States Manufacturing Supply Chain Distribution Regulation BioPharmaceutical

More from Manufacturing

More from Compliance

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window